Naloxone Talk Sheds Light On Switch Research Future

FDA’s 2012 workshop on potential nonprescription use of naloxone for opioid overdoses underscored the potential usefulness of human factors research in the evolving landscape for switch. Largely considered a sub-category of self-selection studies, human factors research could gain importance as FDA moves into considering novel switches.